NAT2 and tuberculosis: Apart from the adverse drug reactions that could be avoided by individualising isoniazid dosage according to NAT2 phenotypes, incorrect dosage may contribute to the growing prevalence of multi-drug resistant tuberculosis.37 The unavailability of routine isoniazid genotyping could thus be considered a major limitation of current tuberculosis treatment protocols.